Who invested in Homology Medicines?
Homology Medicines's investors include Temasek Holdings, ARCH Venture Partners, 5AM Ventures, Vivo Capital and Alexandria Real Estate Equities, and 8 more on record.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$144Mraised across 2 rounds since 2017, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
Reported by FinSMEsSEC filing: $84M sold, first sale Jul 2017
From the SEC filings it signed: 4 on the team.
On the board, as filediCameron WheelerKush ParmarMahendra ShahRichard GregorySteven Gillis
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Homology Medicines's investors include Temasek Holdings, ARCH Venture Partners, 5AM Ventures, Vivo Capital and Alexandria Real Estate Equities, and 8 more on record.
Homology Medicines has raised $144M across 2 rounds since 2017.
Homology Medicines's most recent round was an Undisclosed round of $60M in Nov 2020.
Homology Medicines's largest round on record is $84M (Series B), in Aug 2017.
Homology Medicines's first round on record, in Aug 2017, was backed by Alexandria Real Estate Equities, Novartis and HBM and 5 others.
Homology Medicines's latest named round is an Undisclosed round, in Nov 2020.
Homology Medicines is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.